​

Autolus Therapeutics (AUTL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Autolus Therapeutics Revenue Highlights

Latest Revenue (Y)

$1.70M

0

Main Segment (Y)

License

Main Geography (Y)

UNITED STATES

Autolus Therapeutics Revenue by Period

Autolus Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$1.70M-72.59%
2022-12-31$6.19M165.84%
2021-12-31$2.33M862.81%
2020-12-31$242.00K-91.68%
2019-12-31$2.91M178.19%
2018-09-30$1.05M-38.25%
2017-09-30$1.69M39.69%
2016-09-30$1.21M-

Autolus Therapeutics generated $1.70M in revenue during NA 2023, up -72.59% compared to the previous quarter, and up 162.43% compared to the same period a year ago.

Autolus Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30--100.00%
2024-03-31$10.09M468.51%
2023-12-31$1.77M337.19%
2023-09-30$406.00K100.00%
2023-06-30--100.00%
2023-03-31$1.29M-66.22%
2022-12-31$3.83M61.46%
2022-09-30$2.37M100.00%
2022-06-30--100.00%
2022-03-31$166.00K-79.83%
2021-12-31$823.00K248.73%
2021-09-30$236.00K-84.34%
2021-06-30$1.51M460.22%
2021-03-31$269.00K-130.81%
2020-12-31$-873.00K-460.74%
2020-09-30$242.00K-17.41%
2020-06-30$293.00K-13.31%
2020-03-31$338.00K9.39%
2019-12-31$309.00K4.04%
2019-09-30$297.00K-12.13%
2019-06-30$338.00K-82.79%
2019-03-31$1.96M563.51%
2018-12-31$296.00K-3.58%
2018-09-30$307.00K-30.70%
2018-06-30$443.00K3.99%
2018-03-31$426.00K4.93%
2017-09-30$406.00K-
2017-06-30$406.00K-7.83%
2017-03-31$440.50K-
2016-12-31$440.50K-

Autolus Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Autolus Therapeutics Revenue Breakdown

Autolus Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20
License$1.70M$3.50M$242.00K-
Royalty----
Grant-$166.00K$823.00K$1.47M

Autolus Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 20Sep 20
License-$10.10M-$242.00K
Grant--$1.03M$438.00K

Autolus Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
UNITED STATES$1.35M$6.19M$1.51M

Autolus Therapeutics's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (100.00%).

Quarterly Revenue by Country

CountryMar 24Sep 20
UNITED STATES--
GERMANY$10.09M-
License-$242.00K
Grant-$438.00K

Autolus Therapeutics's latest quarterly revenue breakdown by geography, as of Mar 24: GERMANY (100.00%).

Autolus Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals$380.79M$416.00K
APLSApellis Pharmaceuticals$366.28M$176.57M
IKNAIkena Oncology$9.16M-
BOLTBolt Biotherapeutics$7.88M$1.14M
AUTLAutolus Therapeutics$1.70M-
LYRALyra Therapeutics$1.56M$195.00K
MNOVMediciNova$1.00M-
ANEBAnebulo Pharmaceuticals--
CGEMCullinan Oncology--
RZLTRezolute--
XFORX4 Pharmaceuticals-$560.00K
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
CELCCelcuity--

AUTL Revenue FAQ

What is Autolus Therapeutics’s yearly revenue?

Autolus Therapeutics's yearly revenue for 2023 was $1.7M, representing a decrease of -72.59% compared to 2022. The company's yearly revenue for 2022 was $6.19M, representing an increase of 165.84% compared to 2021. AUTL's yearly revenue for 2021 was $2.33M, representing an increase of 862.81% compared to 2020.

What is Autolus Therapeutics’s quarterly revenue?

Autolus Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). AUTL's quarterly revenue for Q1 2024 was $10.09M, a 468.51% increase from the previous quarter (Q4 2023), and a 681.04% increase year-over-year (Q1 2023).

What is Autolus Therapeutics’s revenue growth rate?

Autolus Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -27.12%, and for the last 5 years (2019-2023) was -41.61%.

What are Autolus Therapeutics’s revenue streams?

Autolus Therapeutics's revenue streams in c 23 are License

What is Autolus Therapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Autolus Therapeutics was License. This segment made a revenue of $1.7M, representing 100.00% of the company's total revenue.